WASHINGTON (Reuters) - Researchers have developed a new medical technique that may prevent some women with breast cancer from undergoing surgery while undergoing treatment, US researchers said on Monday.

According to the First For Women website, the TGen Institute for Gene Research in the United States has developed a viable technique for blood tests in women with breast cancer.

The source said that these analyzes, which will be conducted in blood, will be more effective than the current methods, nearly a hundred times, ie, it will produce something like a medical revolution.

Breast cancer is currently being treated with drugs that attack tumors and lead to atrophy, and at a later stage, women undergo surgery to remove the remaining tumors, according to Sky News.

But what is happening now is that some women have surgery, after the treatment, and then doctors do not find any remaining cells.

Since 30 percent of women with breast cancer undergo surgery without need, after treatment, blood tests promise a promising solution.

The new blood analysis is called "TARDIS" and the researchers say it can detect tumors even in their early stages.

This revolutionary medical analysis can detect the tumor DNA in all stages of malignant disease.

Since this analysis monitors the tumor DNA, even if it is very low in the blood, doctors are better informed about the condition of the patient, which was not available before.